title: Treatment of Mycobacterium marinum facial abscess using clarithromycin.
authors.affiliation: Department of Pediatrics, Alberta Children's Hospital, Calgary, Canada.
authors.forename: S M
authors.initials: SM
authors.lastname: Kuhn
authors.forename: W
authors.initials: W
authors.lastname: Rosen
authors.forename: A
authors.initials: A
authors.lastname: Wong
authors.forename: T
authors.initials: T
authors.lastname: Jadavji
mesh_terms: D000038:Abscess / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D002675:Child, Preschool; D017291:Clarithromycin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004322:Drainage; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005145:Face; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D009170:Nontuberculous Mycobacteria / Q000187:drug effects / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use; D018461:Soft Tissue Infections / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D014374:Tuberculin Test
chemical_list: D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D017291:Clarithromycin; D012293:Rifampin